LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 108 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,725 | -49.8% | 17,774 | -25.4% | 0.00% | – |
| Q1 2024 | $35,284 | +47.4% | 23,841 | +8.5% | 0.00% | – |
| Q4 2023 | $23,941 | +21.0% | 21,964 | +31.0% | 0.00% | – |
| Q3 2023 | $19,784 | -16.4% | 16,766 | -0.1% | 0.00% | – |
| Q2 2023 | $23,666 | -34.3% | 16,784 | -28.6% | 0.00% | – |
| Q1 2022 | $36,000 | -46.3% | 23,513 | -14.2% | 0.00% | – |
| Q4 2021 | $67,000 | +67.5% | 27,397 | +70.5% | 0.00% | – |
| Q3 2021 | $40,000 | -55.6% | 16,071 | -48.9% | 0.00% | – |
| Q2 2021 | $90,000 | +592.3% | 31,459 | +114.6% | 0.00% | – |
| Q4 2019 | $13,000 | +8.3% | 14,661 | +19.0% | 0.00% | – |
| Q3 2019 | $12,000 | – | 12,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $52,403,228 | 3.69% |
| Raffles Associates | 1,536,946 | $2,305,419 | 3.14% |
| Defender Capital, LLC. | 5,136,085 | $7,704,128 | 2.69% |
| Prescott General Partners LLC | 1,851,851 | $2,777,777 | 0.22% |
| DAFNA Capital Management LLC | 140,000 | $210,000 | 0.06% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $67,500 | 0.05% |
| CTC Capital Management, LLC | 14,100 | $21,150 | 0.04% |
| Diametric Capital, LP | 50,875 | $76,313 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $1,172,649 | 0.03% |
| One68 Global Capital, LLC | 13,377 | $20,066 | 0.03% |